Publications:

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy.

Esmo Open

Takada, K K; Takamori, S S; Shimokawa, M M; Toyokawa, G G; Shimamatsu, S S; Hirai, F F; Tagawa, T T; Okamoto, T T; Hamatake, M M; Tsuchiya-Kawano, Y Y; Otsubo, K K; Inoue, K K; Yoneshima, Y Y; Tanaka, K K; Okamoto, I I; Nakanishi, Y Y; Mori, M M

Publication Date: 2021-12-20

Variant appearance in text: ALK: A68A

PubMed Link: 34942439

Variant Present in the following documents:

• Main text

View BVdb publication page